Gregg H Alton
CIK 1334682 · Chief Patient Officer · last filed 2026-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.55M
Companies
7
Total Filings
212
Lifetime Open-Market Net
-$173.46M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CORT | Director | — | $82.91 | — | $0 | 8 | 2026-05-26 |
| NVAX | Director | 28,805 | $8.88 | $255.8K | $0 | 9 | 2025-06-24 |
| RENOVARO INC. (RENB) Delisted | Director | — | $1.54 | — | $0 | 2 | 2024-06-27 |
| RENOVARO INC. (ENOB) Delisted | Director | — | $0.70 | — | $0 | 3 | 2023-01-05 |
| GILD | Chief Patient Officer | 58,046 | $125.59 | $7.29M | -$173.46M | 180 | 2019-03-05 |
| Eiger BioPharmaceuticals, Inc. (CLDN) Delisted | Director | — | — | — | $0 | 1 | 2015-06-05 |
| Sonoma Pharmaceuticals, Inc. (OCLS) Delisted | Director | — | — | — | $0 | 9 | 2012-10-02 |
Recent Filings · Page 2 of 22
212 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-05-23 | CORT | Grant (A) | — | $0 | EDGAR |
| 2023-01-05 | RENOVARO INC. (ENOB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-21 | NVAX | Exer (M) | +700 | $0 | EDGAR |
| 2022-06-14 | NVAX | Grant (A) | — | $0 | EDGAR |
| 2022-06-02 | CORT | Grant (A) | — | $0 | EDGAR |
| 2021-12-28 | RENOVARO INC. (ENOB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-22 | RENOVARO INC. (ENOB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-22 | NVAX | Grant (A) | — | $0 | EDGAR |
| 2021-05-28 | CORT | Grant (A) | — | $0 | EDGAR |
| 2020-11-03 | NVAX | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.